Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer

Lukas Käsmann, Stefan Janssen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

Abstract

Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all patients. To contribute to better personalization of the radiochemotherapy programs, this study compared two radiotherapy doses and 10 characteristics for survival. Patients and Methods: In 71 patients receiving radiochemotherapy for small-cell lung cancer, the radiation dose given as equivalent dose in 2 Gy fractions (EQD2: <56 vs. ?56 Gy) plus 10 characteristics, namely gender, age, Karnofsky performance score, T-category, Ncategory, tumor stage, pack years, smoking during radiotherapy, respiratory insufficiency and hemoglobin prior to radiotherapy, were evaluated for survival. Results: On multivariate analysis, EQD2 ?56 Gy (p=0.003), female gender (p=0.029), Karnofsky performance score >70 (p<0.001), very limited disease (p=0.043) and pre-radiotherapy hemoglobin ?12 g/dl (p=0.044) were significantly associated with better survival. Conclusion: This study identified several independent predictors of survival after radiochemotherapy of small-cell lung cancer. A radiation dose of ?56 Gy resulted in better survival than lower doses.

Original languageEnglish (US)
Pages (from-to)1089-1092
Number of pages4
JournalAnticancer Research
Volume36
Issue number3
StatePublished - Mar 1 2016

Fingerprint

Small Cell Lung Carcinoma
Chemoradiotherapy
Radiation
Survival
Radiotherapy
Hemoglobins

Keywords

  • Potential prognostic factors
  • Radiation dose
  • Radiochemotherapy
  • Small-cell lung cancer
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Käsmann, L., Janssen, S., Schild, S. E., & Rades, D. (2016). Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer. Anticancer Research, 36(3), 1089-1092.

Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer. / Käsmann, Lukas; Janssen, Stefan; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 36, No. 3, 01.03.2016, p. 1089-1092.

Research output: Contribution to journalArticle

Käsmann, L, Janssen, S, Schild, SE & Rades, D 2016, 'Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer', Anticancer Research, vol. 36, no. 3, pp. 1089-1092.
Käsmann L, Janssen S, Schild SE, Rades D. Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer. Anticancer Research. 2016 Mar 1;36(3):1089-1092.
Käsmann, Lukas ; Janssen, Stefan ; Schild, Steven E. ; Rades, Dirk. / Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer. In: Anticancer Research. 2016 ; Vol. 36, No. 3. pp. 1089-1092.
@article{1fa72c77fa0b47f2b456c270c5b00a19,
title = "Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer",
abstract = "Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all patients. To contribute to better personalization of the radiochemotherapy programs, this study compared two radiotherapy doses and 10 characteristics for survival. Patients and Methods: In 71 patients receiving radiochemotherapy for small-cell lung cancer, the radiation dose given as equivalent dose in 2 Gy fractions (EQD2: <56 vs. ?56 Gy) plus 10 characteristics, namely gender, age, Karnofsky performance score, T-category, Ncategory, tumor stage, pack years, smoking during radiotherapy, respiratory insufficiency and hemoglobin prior to radiotherapy, were evaluated for survival. Results: On multivariate analysis, EQD2 ?56 Gy (p=0.003), female gender (p=0.029), Karnofsky performance score >70 (p<0.001), very limited disease (p=0.043) and pre-radiotherapy hemoglobin ?12 g/dl (p=0.044) were significantly associated with better survival. Conclusion: This study identified several independent predictors of survival after radiochemotherapy of small-cell lung cancer. A radiation dose of ?56 Gy resulted in better survival than lower doses.",
keywords = "Potential prognostic factors, Radiation dose, Radiochemotherapy, Small-cell lung cancer, Survival",
author = "Lukas K{\"a}smann and Stefan Janssen and Schild, {Steven E.} and Dirk Rades",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "36",
pages = "1089--1092",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Impact of the radiation dose on survival after radiochemotherapy for small-cell lung cancer

AU - Käsmann, Lukas

AU - Janssen, Stefan

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all patients. To contribute to better personalization of the radiochemotherapy programs, this study compared two radiotherapy doses and 10 characteristics for survival. Patients and Methods: In 71 patients receiving radiochemotherapy for small-cell lung cancer, the radiation dose given as equivalent dose in 2 Gy fractions (EQD2: <56 vs. ?56 Gy) plus 10 characteristics, namely gender, age, Karnofsky performance score, T-category, Ncategory, tumor stage, pack years, smoking during radiotherapy, respiratory insufficiency and hemoglobin prior to radiotherapy, were evaluated for survival. Results: On multivariate analysis, EQD2 ?56 Gy (p=0.003), female gender (p=0.029), Karnofsky performance score >70 (p<0.001), very limited disease (p=0.043) and pre-radiotherapy hemoglobin ?12 g/dl (p=0.044) were significantly associated with better survival. Conclusion: This study identified several independent predictors of survival after radiochemotherapy of small-cell lung cancer. A radiation dose of ?56 Gy resulted in better survival than lower doses.

AB - Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all patients. To contribute to better personalization of the radiochemotherapy programs, this study compared two radiotherapy doses and 10 characteristics for survival. Patients and Methods: In 71 patients receiving radiochemotherapy for small-cell lung cancer, the radiation dose given as equivalent dose in 2 Gy fractions (EQD2: <56 vs. ?56 Gy) plus 10 characteristics, namely gender, age, Karnofsky performance score, T-category, Ncategory, tumor stage, pack years, smoking during radiotherapy, respiratory insufficiency and hemoglobin prior to radiotherapy, were evaluated for survival. Results: On multivariate analysis, EQD2 ?56 Gy (p=0.003), female gender (p=0.029), Karnofsky performance score >70 (p<0.001), very limited disease (p=0.043) and pre-radiotherapy hemoglobin ?12 g/dl (p=0.044) were significantly associated with better survival. Conclusion: This study identified several independent predictors of survival after radiochemotherapy of small-cell lung cancer. A radiation dose of ?56 Gy resulted in better survival than lower doses.

KW - Potential prognostic factors

KW - Radiation dose

KW - Radiochemotherapy

KW - Small-cell lung cancer

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84991694238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991694238&partnerID=8YFLogxK

M3 - Article

C2 - 26977003

AN - SCOPUS:84991694238

VL - 36

SP - 1089

EP - 1092

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -